Aligos Therapeutics, Inc. (ALGS)
Nasdaq: ALGS · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2020
Who owns Aligos Therapeutics, Inc.
As filed with the SECHolders of 5% or more
3
Alyeska Investment Group, L.P. holds 9.99% of Common Stock, par value, $0.0001 per share, as its SCHEDULE 13G filed May 15, 2025 says.
Directors and officers
10
report now, of 18 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Alyeska Investment Group, L.P.
SCHEDULE 13G · filed May 15, 2025 · Common Stock, par value, $0.0001 per share
Lawrence M. Blatt
SCHEDULE 13D · filed Jun 24, 2026 · Common Stock, par value, $0.0001 per share · 5.1% in May 15, 2026
Sio Capital Management, LLC
SCHEDULE 13G/A · filed Feb 11, 2026 · Common Stock, par value, $0.0001 per share · 5.49% in Aug 13, 2025
Armistice Capital, LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value, $0.0001 per share · reported falling below 5%
Woodline Partners LP
SCHEDULE 13G/A · filed May 15, 2026 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.4% in Feb 17, 2026
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2025 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.38% in Feb 12, 2025
EcoR1 Capital, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock · reported falling below 5%
What ALGS reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 9, 2023.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.